Feed Category: Gene Therapy

– Conference Call and Webcast Today, February 6, 2023 at 4:30 p.m. ETPASADENA, Calif., February 06, 2023–(BUSINESS WIRE)–Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial… [Read More]

Shares of Intellia Therapeutics, Inc. (NTLA) have gained 13.5% over the past four weeks to close the last trading session at $43.23, but there could… [Read More]

Shares of Fate Therapeutics (FATE) have gained 62% over the past four weeks to close the last trading session at $6.87, but there could still… [Read More]

The tech-heavy Nasdaq represents a collection of more risky stocks than the other major indexes and that is reflected by a poorer performance in bear… [Read More]

With its share price off by 11% over the past 12 months, CRISPR Therapeutics (NASDAQ: CRSP) may be down, but it’s far from being out…. [Read More]

THOUSAND OAKS, Calif., February 06, 2023–(BUSINESS WIRE)–Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform… [Read More]

Insiders who bought Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) stock lover the last 12 months are probably not as affected by last week’s 7.7% loss. Reason being,… [Read More]

In stock investing, it’s easy to focus on big names and blue-chip companies since they are frequently reported in financial media. Conversely, smaller companies, but… [Read More]

CRISPR Therapeutics AG (CRSP) closed at $55.27 in the latest trading session, marking a -1.51% move from the prior day. This move lagged the S&P… [Read More]

THOUSAND OAKS, Calif., February 03, 2023–(BUSINESS WIRE)–Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform… [Read More]

It has been an interesting earnings season for the Medical sector so far. The sector primarily comprises pharma/biotech and medical device companies.Several large drug and… [Read More]

Shares of Editas Medicine (NASDAQ: EDIT) were up 21.1% for the week as of Friday morning, according to data provided by S&P Global Market Intelligence…. [Read More]